Cutia Therapeutics
HKEX:2487
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
|
C
|
CWG Holdings Bhd
KLSE:CEPAT
|
MY |
|
Nishi-Nippon Financial Holdings Inc
TSE:7189
|
JP |
|
Tata Coffee Ltd
NSE:TATACOFFEE
|
IN |
|
National Standard (India) Ltd
BSE:504882
|
IN |
|
Laster Tech Co Ltd
TWSE:3346
|
TW |
|
Gillette India Ltd
NSE:GILLETTE
|
IN |
|
E
|
Edianyun Ltd
HKEX:2416
|
CN |
|
F&M Co Ltd
TSE:4771
|
JP |
|
K
|
Kossan Rubber Industries Bhd
KLSE:KOSSAN
|
MY |
Cutia Therapeutics
Cutia Therapeutics is a holding company that engages in the research and development of dermatology treatment solutions and products through its subsidiaries. The company is headquartered in Shanghai, Shanghai and currently employs 175 full-time employees. The company went IPO on 2023-06-12. The firm is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The firm is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The firm conducts its businesses in the domestic market and overseas markets.
Cutia Therapeutics is a holding company that engages in the research and development of dermatology treatment solutions and products through its subsidiaries. The company is headquartered in Shanghai, Shanghai and currently employs 175 full-time employees. The company went IPO on 2023-06-12. The firm is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The firm is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The firm conducts its businesses in the domestic market and overseas markets.
